Insulin
Lilly’s Once-Weekly Insulin Delivers Similar A1C Reduction to Daily Basal Insulin
Could an Intestinal Procedure Be the Future of Type 2 Diabetes Therapy?
Fractyl Health, a company that has pioneered a procedure called Duodenal Mucosal Resurfacing, announced on Feb. 8 that it has begun offering its procedure as a type 2 diabetes treatment in Germany.
Top Diabetes Drugs Get Lower Medicare Pricing
Sanofi to Build New State-of-the-Art Insulin Plant
FDA Surprises Novo Nordisk by Not Approving Once-Weekly Insulin
